Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)

SHE:301301 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,088	760.94	1,632	510.05	510.2
Trading Asset Securities	-	-	1.15	1.21	0.42
Cash & Short-Term Investments	1,088	760.94	1,633	511.26	510.62
Cash Growth	43.03%	-53.41%	219.44%	0.13%	192.94%
Accounts Receivable	1,572	1,403	1,417	1,178	1,220
Other Receivables	0.53	0.63	2.59	1.19	1.73
Receivables	1,573	1,404	1,420	1,179	1,222
Inventory	1,342	1,676	1,384	1,453	1,449
Other Current Assets	141.02	114.94	91.25	72.12	134.88
Total Current Assets	4,144	3,956	4,528	3,216	3,316
Property, Plant & Equipment	6,046	5,870	5,539	5,920	6,293
Long-Term Investments	70.69	6.78	6.93	-	-
Goodwill	1.37	1.37	1.37	1.37	1.37
Other Intangible Assets	235.83	257.99	283.07	271.83	211.54
Long-Term Deferred Tax Assets	20.9	21.65	11.34	6.96	4.02
Long-Term Deferred Charges	1.54	2.42	3.4	4.72	39.93
Other Long-Term Assets	33.25	21.64	17.97	40.94	54.46
Total Assets	10,554	10,139	10,390	9,462	9,920
Accounts Payable	383.33	479.98	282.99	427.66	420.63
Accrued Expenses	64.32	31.57	66.32	20.7	23.09
Short-Term Debt	210.15	850.68	978.83	700.35	790.75
Current Portion of Long-Term Debt	608.16	538.36	847.26	878.17	628.27
Current Portion of Leases	8.9	3.8	1.88	1.02	-
Current Income Taxes Payable	66.37	36.52	24.79	0.14	0.17
Current Unearned Revenue	66.82	28.94	38	21.26	15.78
Other Current Liabilities	539.49	565.85	467.33	513.58	521.87
Total Current Liabilities	1,948	2,536	2,707	2,563	2,401
Long-Term Debt	146	357.33	1,428	2,092	2,846
Long-Term Leases	451.12	188.12	10.2	3.13	-
Long-Term Unearned Revenue	92.51	83.74	34.24	26.22	7.92
Long-Term Deferred Tax Liabilities	-	0.31	0.08	-	-
Other Long-Term Liabilities	-	0.08	-	-	-
Total Liabilities	2,637	3,165	4,180	4,684	5,254
Common Stock	2,227	2,223	2,223	2,000	2,000
Additional Paid-In Capital	3,284	3,252	3,229	2,431	2,431
Retained Earnings	2,386	1,486	752.21	340.7	229.35
Comprehensive Income & Other	-0.1	-	-	-	-
Total Common Equity	7,898	6,960	6,204	4,771	4,660
Minority Interest	18.83	12.87	6	6	6
Shareholders' Equity	7,916	6,973	6,210	4,777	4,666
Total Liabilities & Equity	10,554	10,139	10,390	9,462	9,920
Total Debt	1,424	1,938	3,266	3,675	4,265
Net Cash (Debt)	-336	-1,177	-1,633	-3,163	-3,754
Net Cash Per Share	-0.15	-0.53	-0.83	-1.70	-1.88
Filing Date Shares Outstanding	2,227	2,223	2,223	2,000	2,000
Total Common Shares Outstanding	2,227	2,223	2,223	2,000	2,000
Working Capital	2,197	1,421	1,820	653.24	915.35
Book Value Per Share	3.55	3.13	2.79	2.39	2.33
Tangible Book Value	7,660	6,701	5,920	4,498	4,447
Tangible Book Value Per Share	3.44	3.01	2.66	2.25	2.22
Buildings	3,060	2,779	2,637	2,560	2,461
Machinery	6,226	5,861	5,815	5,725	5,449
Construction In Progress	285.31	537.8	60.12	96.38	356.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.